Stephanie L. Graff, MD

Stephanie Graff, MD, concludes the discussion with thoughts on endocrine therapies in development for patients with ER+/HER2- metastatic breast cancer.

An expert on breast cancer reviews currently available tests for ESR1 mutations and provides clinical insights on best practices for testing.

Stephanie L. Graff, MD, provides an overview of ESR1 mutations in ER+/HER2- metastatic breast cancer, highlighting their prevalence, clinical implications, and challenges.